Canada markets closed

Lexicon Pharmaceuticals, Inc. (LXRX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.5400-0.0200 (-1.28%)
At close: 04:00PM EDT
1.5200 -0.02 (-1.30%)
After hours: 06:49PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 384.13M
Enterprise Value 320.17M
Trailing P/E 3.74
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)286.51
Price/Book (mrq)4.13
Enterprise Value/Revenue 265.92
Enterprise Value/EBITDA -1.96

Trading Information

Stock Price History

Beta (5Y Monthly) 1.27
52-Week Change 3-34.45%
S&P500 52-Week Change 324.19%
52 Week High 33.7900
52 Week Low 30.9200
50-Day Moving Average 32.1882
200-Day Moving Average 31.6855

Share Statistics

Avg Vol (3 month) 34.56M
Avg Vol (10 day) 33.14M
Shares Outstanding 5246.24M
Implied Shares Outstanding 6246.24M
Float 8100.03M
% Held by Insiders 11.66%
% Held by Institutions 182.17%
Shares Short (Apr 15, 2024) 420.12M
Short Ratio (Apr 15, 2024) 46.39
Short % of Float (Apr 15, 2024) 442.17%
Short % of Shares Outstanding (Apr 15, 2024) 48.17%
Shares Short (prior month Mar 15, 2024) 421.35M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:7
Last Split Date 3May 21, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-6,657.69%

Management Effectiveness

Return on Assets (ttm)-50.67%
Return on Equity (ttm)-168.50%

Income Statement

Revenue (ttm)1.2M
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)2,407.10%
Gross Profit (ttm)N/A
EBITDA -171.2M
Net Income Avi to Common (ttm)-177.12M
Diluted EPS (ttm)-0.8000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)170.03M
Total Cash Per Share (mrq)0.69
Total Debt (mrq)106.06M
Total Debt/Equity (mrq)113.91%
Current Ratio (mrq)5.60
Book Value Per Share (mrq)0.38

Cash Flow Statement

Operating Cash Flow (ttm)-161.9M
Levered Free Cash Flow (ttm)-94.97M